AMELIORATIVE EFFECT OF THE METHANOLIC EXTRACT OF SPIROGYRA VARIANS ON HYPERGLYCEMIA AND NEPHROTOXICITY IN MALE RATS INDUCED WITH STREPTOZOTOCIN AND GENTAMICIN
Downloads
Spirogyra varians is a huge green alga that is rich in biological and similar active compounds with various pharmacological elements and recorded their therapeutic potential. This study evaluates the therapeutic efficiency of the methanolic extract of Spirogyra varians obtainable in diabetes and renal failure with an experimentation model in a sampled mices. The alga biomass was obtained, extracted and purified and its chemical elements was examined with the use of albino gas chromatography, mass spectrometry (GC–MS). The experimentation was carried out on the male albino laboratory with rats (200g) which was maintained under measured room and was randomly separated in to experimentation categories which include: (8 rats/group). Diabetes was tempted through streptozotocin (STZ), and nephrotoxicity was tempted with gentamicin (GN). After this process the rats obtained graded an oral dose of the methanolic algal throughout the period of treatment. The findings showed the glucose level was elevated as well as the glucose levels and similarly the insulin levels also decreased to confirm the successful induction of diabetes. The renal function biomarkers which include urea and creatinine indicated an elevation. The isolated groups displayed essential enhancement following algal the administration of extract with does-inclined differences. The renal injury evaluation with the use of kidney injury molecule-1 (KIM-1) discovered an essential enhancement in the treatment groups, though, the effect was not the same across all the administered doses. Oxidative stress markers again indicated reformed levels of malondialdehyde (MDA) and superoxide dismutase (SOD) this follows the treatment and induction to support the inclusion of antioxidant mechanisms. Generally, the findings present that the methanolic extract of Spirogyra varians uses significant antihyperglycemic and nephroprotective impacts in a diabetic nephropathy model to accompany the improvement in renal function oxidative stress status and biomarkers.
A. Petersmann et al., “Definition, classification and diagnosis of diabetes mellitus,” Experimental and Clinical Endocrinology & Diabetes, vol. 127, no. S01, pp. S1–S7, 2019.
D. Mahmood, B. K. Singh, and M. Akhtar, “Diabetic neuropathy: therapies on the horizon,” Journal of Pharmacy and Pharmacology, vol. 61, no. 9, pp. 1137–1145, 2009.
S. Shelbaya et al., “Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients,” European Review for Medical and Pharmacological Sciences, vol. 16, no. 2, pp. 176–182, 2012.
D. Glovaci, W. Fan, and N. D. Wong, “Epidemiology of diabetes mellitus and cardiovascular disease,” Current Cardiology Reports, vol. 21, pp. 1–8, 2019.
J. Kaufman, M. Dhakal, B. Patel, and R. Hamburger, “Community-acquired acute renal failure,” American Journal of Kidney Diseases, vol. 17, no. 2, pp. 191–198, 1991.
J. B. Patel and A. Sapra, “Nephrotoxic medications,” 2020.
A. Džidić-Krivić et al., “Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies,” Chemico-Biological Interactions, vol. 388, 110838, 2024.
L. Pereira and A. Valado, “Algae-derived natural products in diabetes and its complications—current advances and future prospects,” Life, vol. 13, no. 9, 1831, 2023.
L. A. Minhas et al., “Algae-derived bioactive compounds as potential pharmaceuticals for cancer therapy: A comprehensive review,” Algal Research, vol. 78, 103396, 2024.
A. Bocanegra, A. Macho-González, A. Garcimartín, J. Benedí, and F. J. Sánchez-Muniz, “Whole alga, algal extracts, and compounds as ingredients of functional foods,” International Journal of Molecular Sciences, vol. 22, no. 8, 3816, 2021.
E. S. Sruthy and E. C. K. Baiju, “Exploration of secondary metabolites from green algae as antimicrobial agents,” Botanica Serbica, vol. 48, no. 2, pp. 127–140, 2024.
T. Takano et al., “Identification of 13 Spirogyra species by traits of sexual reproduction,” Scientific Reports, vol. 9, 2019.
K. Yeshi, D. Crayn, E. Ritmejerytė, and P. Wangchuk, “Plant secondary metabolites produced in response to abiotic stresses,” Molecules, vol. 27, no. 1, 313, 2022.
T. Behl et al., “Alkaloidal phytoconstituents for diabetes management,” Molecules, vol. 27, no. 18, 5851, 2022.
S. S. Ghwenm, F. S. Kata, and A. M. Athbi, “Hypoglycemic and antioxidant effect of the ethanol extract of Chlorella vulgaris in alloxan-induced diabetic mice,” Biochemical & Cellular Archives, vol. 20, 2020.
F. Z. Labbaci and F. O. Boukortt, “Beneficial effects of Algerian green alga Ulva lactuca on insulin resistance,” Preventive Nutrition and Food Science, vol. 25, no. 4, pp. 353–360, 2020.
A. S. Hussein, M. M. Zidan, and H. M. Hwihy, “Therapeutic effects of marine algae extracts on diabetic albino rats,” Egyptian Journal of Aquatic Biology & Fisheries, vol. 27, no. 5, 2023.
G. W. Prescott, Algae of the Western Great Lakes Area, 6th ed. Dubuque: Wm. C. Brown Publishers, 1975.
M. D. Guiry, “AlgaeBase,” World-wide electronic publication, 2013.
V. E. Weideman, P. R. Walne, and F. R. Tainor, “A new technique for obtaining axenic cultures of algae,” Canadian Journal of Botany, vol. 42, pp. 958–959, 1984.
N. D. Salman, A. S. Dwaish, and S. M. Kareem, “Effect of methanolic extract of Spirogyra varians on biofilm genes expression,” 2024.
K. K. Al-Fartosi, Physiological Studies of the Effects of Benzene in Laboratory Mice and Humans, PhD thesis, University of Basrah, 2004.
A. Ontawong et al., “Antioxidant and renoprotective effects of Spirogyra neglecta extract in diabetic rats,” BioMed Research International, 2013.
B. Mesbahzadeh et al., “Beneficial effects of Spirogyra neglecta extract on antioxidant factors,” Biomolecular Concepts, vol. 9, no. 1, pp. 184–189, 2018.
R. Thongrung et al., “Moringa oleifera leaf extract ameliorates early stages of diabetic nephropathy,” Journal of Applied Pharmaceutical Science, vol. 13, no. 8, pp. 158–166, 2023.
I. Sharma et al., “Modulation of gentamicin-induced acute kidney injury,” JCI Insight, vol. 7, no. 6, 2022.
N. W. Tietz, Clinical Guide to Laboratory Tests, 3rd ed. Philadelphia: Saunders, 1995.
V. S. Vaidya et al., “Kidney injury molecule-1 outperforms traditional biomarkers,” Nature Biotechnology, vol. 28, no. 5, pp. 478–485, 2010.
C. Gopu et al., “GC-MS analysis of bioactive compounds in plant extracts,” Journal of Medicinal Plants Studies, vol. 9, no. 3, pp. 209–218, 2021.
[30] C. Srimaroeng et al., “Antidiabetic and renoprotective effects of Cladophora glomerata extract,” Journal of Diabetes Research, 2015.
A. Ghasemi and S. Jeddi, “Streptozotocin as a tool for induction of rat models of diabetes,” EXCLI Journal, vol. 22, pp. 274–292, 2023.
H. U. Rehman, K. Ullah, and A. Rasool, “Comparative impact of streptozotocin on glucose homeostasis,” Scientific Reports, vol. 13, 7921, 2023.
A. Ghasemi, S. Khalifi, and S. Jeddi, “Streptozotocin-nicotinamide-induced rat model of type 2 diabetes,” Acta Physiologica Hungarica, vol. 101, pp. 408–420, 2014.
N. Rahman et al., “Molecular docking of isolated alkaloids for α-glucosidase inhibition,” Biomolecules, vol. 9, no. 10, 544, 2019.
J. Kellogg, M. H. Grace, and M. A. Lila, “Phlorotannins from Alaskan seaweed inhibit carbolytic enzyme activity,” Marine Drugs, vol. 12, no. 10, pp. 5277–5294, 2014.
A. C. Boschero and E. Delattre, “Mechanism of gentamicin-inhibited insulin release,” Archives Internationales de Pharmacodynamie et de Thérapie, vol. 273, pp. 167–176, 1985.
A. A. Alrasheedi, A. I. Basnawi, and M. A. Althaiban, “Effects of Spirulina platensis on renal function and antioxidant defence,” Journal of Functional Foods, vol. 122, 106485, 2024.
B. Yongkhamcha and N. Buddhakala, “Phytochemical compositions and anti-inflammatory activity of Spirogyra neglecta extracts,” Trends in Sciences, vol. 20, no. 4, 2023.
K. Kolefer, D. Miaffo, and R. Ponka, “Evaluation of antidiabetic properties of Ficus vallis-choudae,” The Scientific World Journal, 2021.
S. Kumari et al., “Nephroprotective effect of vanillic acid in diabetic rats,” Journal of Diabetes & Metabolic Disorders, vol. 20, pp. 571–582, 2021.
G. L. King and M. R. Loeken, “Hyperglycemia-induced oxidative stress in diabetic complications,” Histochemistry and Cell Biology, vol. 122, no. 4, pp. 333–338, 2004.
S. V. Suryavanshi and Y. A. Kulkarni, “NF-κB: a potential target in diabetic vascular complications,” Frontiers in Pharmacology, vol. 8, 798, 2017.
M. Boozari and H. Hosseinzadeh, “Natural medicines for acute renal failure,” Phytotherapy Research, vol. 31, no. 12, pp. 1824–1835, 2017.
L. K. Al-Halaseh et al., “Nephroprotective activity of green microalgae,” Journal of Pure and Applied Microbiology, vol. 16, pp. 2775–2782, 2022.
A. A. Sosa, S. H. Bagi, and I. H. Hameed, “Analysis of bioactive compounds using GC-MS,” Journal of Pharmacognosy and Phytotherapy, vol. 8, no. 5, pp. 109–126, 2016.
Y. Chtourou et al., “Renal protective effect of dietary polyphenols in diabetic rats,” Nutrients, vol. 14, no. 14, 2867, 2022.
H. Wang et al., “TNF-α deficiency prevents renal inflammation and oxidative stress,” Kidney and Blood Pressure Research, vol. 42, no. 3, pp. 416–427, 2017.
K. Nagao and T. Yanagita, “Functional lipids in metabolic syndrome,” Journal of Nutritional Science and Vitaminology, vol. 61, pp. S159–S161, 2015.
O. Aizzat et al., “Modulation of oxidative stress by Chlorella vulgaris in STZ-induced diabetic rats,” Advances in Medical Sciences, vol. 55, no. 2, pp. 281–288, 2010.
T. Matsunami et al., “Oxidative stress and gene expression of antioxidant enzymes in diabetic rats,” International Journal of Clinical and Experimental Pathology, vol. 3, no. 2, pp. 177–184, 2009.
L. Rayapu et al., “Protective role of marine macroalgae extracts against STZ-induced diabetic rats,” Journal of Coastal Life Medicine, vol. 5, pp. 521–530, 2017.
A. Ontawong et al., “Cladophora glomerata extract exhibits antioxidant and anti-inflammatory effects,” Nutrition Research and Practice, vol. 18, no. 5, pp. 633–646, 2024.
K. Pourkhalili et al., “Renoprotective effect of fucoidan from seaweed on gentamicin-induced nephrotoxicity,” 2022.
A. M. A. Nahdi, A. John, and H. Raza, “Molecular mechanisms of streptozotocin-induced oxidative stress,” Oxidative Medicine and Cellular Longevity, 2017.
V. Udupa and V. Prakash, “Gentamicin induced acute renal damage evaluated using urinary biomarkers,” Toxicology Reports, vol. 6, pp. 91–99, 2019.
Q. H. Luo et al., “Evaluation of KIM-1 and NGAL as early indicators for nephrotoxicity,” Kidney and Blood Pressure Research, vol. 41, no. 6, pp. 911–918, 2016.
Copyright (c) 2026 Journal of Medical Genetics and Clinical Biology
This work is licensed under a Creative Commons Attribution 4.0 International License.
